Fundraising Fox

BioScout Automated Agricultural Disease Detection

Founded 2019 · 35 employees on LinkedIn · 3 known investors

BioScout provides autonomous, solar-powered air sampling devices that detect and identify airborne fungal spores, combining live spore counts with weather data to give growers, agronomists, and agrochemical distributors disease-risk intelligence for fungicide spray timing. Its system uses patented sensor technology and light microscopy to map crop disease risk and reduce unnecessary fungicide applications.

Also known as BioScout

Founders & leadership

BioScout Automated Agricultural Disease Detection was founded in 2019 by Lewis Collins.

LCLewis Collins
Lewis CollinsinCEO

Investors · 3

Company profile

researched Aug 2026

BioScout operates an airborne particulate detection system for agriculture, centred on autonomous, solar-powered air samplers that capture daily air samples in the field. Captured material is imaged using light microscopy at 5K resolution, which the company states can resolve spores down to two microns, and analysed to produce spore identification and counts. The samplers run continuously with cartridge consumables the company describes as lasting up to a stated field-autonomy period under typical daily sampling, limiting field maintenance.

The workflow described by the company covers patented sensor technology for air sampling, detection and identification of pathogens, disease mapping and ground-based insights, with weather data combined with live spore counts to produce disease-risk outputs in a customer dashboard. The intended applications are changing spray timings, reducing preventative fungicide applications, and supporting reduced-chemistry or biological programs. BioScout publishes case-study claims including reduced spray costs, reduced disease loss per hectare, and value protected per sampler where a total disease loss event is averted.

The company also maintains a detection catalogue organised by crop and region, spanning broadacre/arable, horticulture and viticulture, and offers tailored monitoring where a crop or target disease is not already covered. It publishes technical resources on pathogens and spore trapping, including disease models for Eutypa and Botryosphaeria and material on silver scurf in potatoes.

Business model

BioScout deploys sampler hardware in the field and delivers the resulting spore data and disease-risk intelligence to customers through a dashboard, with detection coverage defined by crop and region and tailored monitoring available on request.

Traction

The company publishes field case studies reporting reduced spray costs and fungicide passes, avoided disease loss per hectare, and return on investment per sampler across a 50-hectare managed area, and lists partners and awards on its site.

Latest developments

In November 2024 the company published work on disease detection models for Eutypa and Botryosphaeria, and earlier in 2024 released guidance on seasonal spore tracking in Australian crops.

Full profile — market position, technology, go-to-market, geography

Market position

BioScout positions its offering as preventative disease management for agriculture, targeting reduced fungicide use and better-timed applications compared with calendar-based or precautionary spraying.

The system automates spore trapping and identification rather than relying on visible symptoms or manual inspection, providing spore detection before disease is visible in the crop, and pairs live spore counts with weather data for spray-timing decisions.

Technology

Autonomous, solar-powered air samplers using patented sensor technology capture airborne particulates continuously. Samples are imaged with light microscopy at 5K resolution, capable of detecting spores down to 2 microns, and AI-based analysis identifies and counts spores. Results are combined with weather data to map disease risk and are delivered to a customer dashboard within a stated turnaround from sample capture. Consumable cartridges support extended field autonomy under typical daily sampling.

Go-to-market

Direct enquiry and consultative sales via the company's website, with a detection catalogue segmented by crop and region and an intake form for agrochemical, broadacre/arable, horticulture, viticulture and research-institution customers.

Growers, agronomists, agrochemical companies and distributors, and research institutions, across broadacre/arable, horticulture and viticulture operations.

Geography

Australia-focused, with content and seasonal spore-tracking guidance oriented to Australian crops and regional detection coverage.

Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Image resolution for spore detectionJan 2024Light microscopy at 5K resolution detects spores down to 2 microns
Managed area per sampler used in ROI calculationJan 202450 hectares
Reduction in spray costs (case study)Jan 202470%

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Research sources · 7

primary sources listed

7 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does BioScout Automated Agricultural Disease Detection do?
BioScout builds AI-powered, solar-powered air samplers that track airborne fungal spores to guide crop disease and fungicide decisions.
Who founded BioScout Automated Agricultural Disease Detection?
BioScout Automated Agricultural Disease Detection was founded by Lewis Collins in 2019.
Who are BioScout Automated Agricultural Disease Detection's investors?
BioScout Automated Agricultural Disease Detection's investors include Artesian, Stoic VC, UniSeed Pty Ltd..